Category Archives: R&D

UK Animal Tests on the Rise

By Sarah Houlton | Published: September 2, 2009
Image by epicnom via Flickr Latest government figures show a big rise in the number of animal experiments, but this is underpinned by an increase in investment in research The number of animal experiments carried out in the UK last year topped 3.5 million, representing a 14 percent increase on the year before. However, industry claims this [...]
Also posted in Global | Tagged , , , , , | Leave a comment

Gilead Making a Bundle

By Walter Armstrong | Published: February 10, 2009
Gilead Sciences has once again proven that independent biotechs can innovate with the best of Big Pharma. The Silicon Valley company’s wizardry at weaving multiple drugs into a single weft enabled it to overthrow GlaxoSmithKline as king of HIV in 2007. Yesterday, at the 16th annual Congress of Retroviruses and Opportunistic Infections (CROI), the biotech [...]
Also posted in Biotech, Emerging Markets | Tagged , , , | Leave a comment

Pharm Exec Podcast Series:
Bill Trombetta Industry Audit (Part 2)

By George Koroneos | Published: January 28, 2009
[display_podcast] Continuing Pharm Exec editor Patrick Clinton’s conversation with Bill Trombetta on the top four pharma companies and what makes them special. Eli Lilly: With double-digit growth in sales, and a solid improvement in revenue per employee, Lilly placed fourth in the Company of the Year rundown. Bill Trombetta explains Lilly’s position as a big/small pharma and [...]
Also posted in Safety, Strategy | Tagged , , , | Leave a comment

Amid Big Pharma Woes, Shire in “Best Shape Ever”

By Joanna Breitstein | Published: November 17, 2008
Angus Russell, Shire’s longtime CFO—now CEO—likens the failing US automobile industry to pharma. “All the problems with the automobile industry were a long time coming,” he says. “It’s just that the SUVs and the relatively cheap price of gas created a bubble, just like a booming economy and blockbusters.” But now that the bubble has burst, [...]
Also posted in Deals, Emerging Markets, Strategy | Tagged , , | 1 Comment

Chantix Nabs Top Doc Ad

By Brittany Agro | Published: September 25, 2008
When 5,742 physicians opt in voting for their favorite medical journal ads over utilizing spare time that never comes, you know it’s a big deal. And yesterday at The Doctor’s Choice awards luncheon sponsored by the Association of Medical Media (AMM), their input was not only showcased on a most refined level but also indicative [...]
Also posted in Events, Marketing | Tagged , , , , , , , , , , , | Leave a comment